Showing 1 - 10 of 29
Persistent link: https://www.econbiz.de/10012243685
Persistent link: https://www.econbiz.de/10012431546
Persistent link: https://www.econbiz.de/10014425408
Persistent link: https://www.econbiz.de/10012216392
Persistent link: https://www.econbiz.de/10012589858
This note is intended to introduce economists to a simple SIR model of the progression of COVID-19 in the United States over the next 12-18 months. An SIR model is a Markov model of the spread of an epidemic in a population in which the total population is divided into categories of being...
Persistent link: https://www.econbiz.de/10012482048
The CDC reports that 1.13 million Americans have died of COVID-19 through June of 2023. I use a model of the impact over the past three years of vaccines and private and public behavior to mitigate disease transmission during the COVID-19 pandemic in the United States to address two questions....
Persistent link: https://www.econbiz.de/10014345630
Persistent link: https://www.econbiz.de/10015189443
We document four facts about the worldwide COVID-19 pandemic that are relevant for those studying the impact of nonpharmaceutical interventions (NPIs) on COVID-19 transmission. First, across all countries and U.S. states that we study, the growth rates of daily deaths from COVID-19 fell from a...
Persistent link: https://www.econbiz.de/10013232101
This paper presents a procedure for estimating and forecasting disease scenarios for COVID-19 using a structural SIR model of the pandemic. Our procedure combines the flexibility of noteworthy reduced-form approaches for estimating the progression of the COVID-19 pandemic to date with the...
Persistent link: https://www.econbiz.de/10012831838